Literature DB >> 30244830

Magnetic Resonance Imaging only Workflow for Radiotherapy Simulation and Planning in Prostate Cancer.

L G W Kerkmeijer1, M Maspero2, G J Meijer2, J R N van der Voort van Zyp2, H C J de Boer2, C A T van den Berg2.   

Abstract

Magnetic resonance imaging (MRI) is often combined with computed tomography (CT) in prostate radiotherapy to optimise delineation of the target and organs-at-risk (OAR) while maintaining accurate dose calculation. Such a dual-modality workflow requires two separate imaging sessions, and it has some fundamental and logistical drawbacks. Due to the availability of new MRI hardware and software solutions, CT examinations can be omitted for prostate radiotherapy simulations. All information for treatment planning, including electron density maps and bony anatomy, can nowadays be obtained with MRI. Such an MRI-only simulation workflow reduces delineation ambiguities, eases planning logistics, and improves patient comfort; however, careful validation of the complete MRI-only workflow is warranted. The first institutes are now adopting this MRI-only workflow for prostate radiotherapy. In this article, we will review technology and workflow requirements for an MRI-only prostate simulation workflow.
Copyright © 2018 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dose calculation; MRI-only radiotherapy; image-guided radiotherapy; magnetic resonance imaging; position verification; prostate cancer

Mesh:

Year:  2018        PMID: 30244830     DOI: 10.1016/j.clon.2018.08.009

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  12 in total

Review 1.  The future of MRI in radiation therapy: Challenges and opportunities for the MR community.

Authors:  Rosie J Goodburn; Marielle E P Philippens; Thierry L Lefebvre; Aly Khalifa; Tom Bruijnen; Joshua N Freedman; David E J Waddington; Eyesha Younus; Eric Aliotta; Gabriele Meliadò; Teo Stanescu; Wajiha Bano; Ali Fatemi-Ardekani; Andreas Wetscherek; Uwe Oelfke; Nico van den Berg; Ralph P Mason; Petra J van Houdt; James M Balter; Oliver J Gurney-Champion
Journal:  Magn Reson Med       Date:  2022-09-21       Impact factor: 3.737

2.  MR SIGnature MAtching (MRSIGMA) with retrospective self-evaluation for real-time volumetric motion imaging.

Authors:  Nathanael Kim; Kathryn R Tringale; Christopher Crane; Neelam Tyagi; Ricardo Otazo
Journal:  Phys Med Biol       Date:  2021-10-26       Impact factor: 4.174

3.  Clinical experience and workflow challenges with magnetic resonance-only radiation therapy simulation and planning for prostate cancer.

Authors:  Neelam Tyagi; Michael J Zelefsky; Andreas Wibmer; Kristen Zakian; Sarah Burleson; Laura Happersett; Aleksi Halkola; Mo Kadbi; Margie Hunt
Journal:  Phys Imaging Radiat Oncol       Date:  2020-10-13

4.  MR-PROTECT: Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria.

Authors:  Emilia Persson; Christian Jamtheim Gustafsson; Petra Ambolt; Silke Engelholm; Sofie Ceberg; Sven Bäck; Lars E Olsson; Adalsteinn Gunnlaugsson
Journal:  Radiat Oncol       Date:  2020-04-09       Impact factor: 3.481

5.  Bulk Anatomical Density Based Dose Calculation for Patient-Specific Quality Assurance of MRI-Only Prostate Radiotherapy.

Authors:  Jae Hyuk Choi; Danny Lee; Laura O'Connor; Stephan Chalup; James S Welsh; Jason Dowling; Peter B Greer
Journal:  Front Oncol       Date:  2019-10-02       Impact factor: 6.244

6.  Fast contour propagation for MR-guided prostate radiotherapy using convolutional neural networks.

Authors:  K A J Eppenhof; M Maspero; M H F Savenije; J C J de Boer; J R N van der Voort van Zyp; B W Raaymakers; A J E Raaijmakers; M Veta; C A T van den Berg; J P W Pluim
Journal:  Med Phys       Date:  2020-01-23       Impact factor: 4.071

7.  Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging.

Authors:  Sarah O S Osman; Emily Russell; Raymond B King; Karen Crowther; Suneil Jain; Cormac McGrath; Alan R Hounsell; Kevin M Prise; Conor K McGarry
Journal:  Radiat Oncol       Date:  2019-12-26       Impact factor: 3.481

8.  Investigation of the clinical inter-observer bias in prostate fiducial marker image registration between CT and MR images.

Authors:  Emilia Persson; Sevgi Emin; Jonas Scherman; Christian Jamtheim Gustafsson; Patrik Brynolfsson; Sofie Ceberg; Adalsteinn Gunnlaugsson; Lars E Olsson
Journal:  Radiat Oncol       Date:  2021-08-16       Impact factor: 3.481

Review 9.  Medical physics challenges in clinical MR-guided radiotherapy.

Authors:  Christopher Kurz; Giulia Buizza; Guillaume Landry; Florian Kamp; Moritz Rabe; Chiara Paganelli; Guido Baroni; Michael Reiner; Paul J Keall; Cornelis A T van den Berg; Marco Riboldi
Journal:  Radiat Oncol       Date:  2020-05-05       Impact factor: 3.481

10.  Clinical implementation of MRI-based organs-at-risk auto-segmentation with convolutional networks for prostate radiotherapy.

Authors:  Mark H F Savenije; Matteo Maspero; Gonda G Sikkes; Jochem R N van der Voort van Zyp; Alexis N T J Kotte; Gijsbert H Bol; Cornelis A T van den Berg
Journal:  Radiat Oncol       Date:  2020-05-11       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.